Bain Capital Life Sciences Investors as of Sept. 30, 2023
Portfolio Holdings for Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors holds 31 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Nuvalent Inc-a (NUVL) | 18.4 | $164M | 3.6M | 45.97 | |
| Pharvaris N V (PHVS) | 11.2 | $100M | 4.8M | 20.87 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 10.8 | $97M | 11M | 9.25 | |
| Springworks Therapeutics (SWTX) | 8.0 | $71M | 3.1M | 23.12 | |
| Disc Medicine (IRON) | 7.0 | $63M | 1.3M | 46.98 | |
| Savara (SVRA) | 6.0 | $54M | 14M | 3.78 | |
| Crinetics Pharmaceuticals In (CRNX) | 4.2 | $38M | 1.3M | 29.74 | |
| Tango Therapeutics (TNGX) | 3.6 | $33M | 2.9M | 11.26 | |
| Natera (NTRA) | 3.5 | $31M | 700k | 44.25 | |
| Cabaletta Bio (CABA) | 3.4 | $30M | 2.0M | 15.22 | |
| Aclaris Therapeutics (ACRS) | 2.6 | $23M | 3.4M | 6.85 | |
| Eqrx | 2.5 | $22M | 10M | 2.22 | |
| X4 Pharmaceuticals (XFOR) | 1.9 | $17M | 16M | 1.09 | |
| Arcutis Biotherapeutics (ARQT) | 1.8 | $16M | 3.0M | 5.31 | |
| Nurix Therapeutics (NRIX) | 1.6 | $14M | 1.8M | 7.86 | |
| Cymabay Therapeutics | 1.5 | $14M | 914k | 14.91 | |
| Dynavax Technologies Corp Com New (DVAX) | 1.5 | $14M | 915k | 14.77 | |
| Annexon (ANNX) | 1.5 | $14M | 5.7M | 2.36 | |
| Marinus Pharmaceuticals Com New (MRNS) | 1.3 | $12M | 1.4M | 8.05 | |
| Mersana Therapeutics (MRSN) | 1.2 | $11M | 8.7M | 1.27 | |
| Rapid Micro Biosystems Class A Com (RPID) | 1.0 | $9.1M | 8.4M | 1.08 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.9 | $8.4M | 2.1M | 3.95 | |
| Solid Biosciences Com New (SLDB) | 0.9 | $7.9M | 3.1M | 2.52 | |
| Atea Pharmaceuticals (AVIR) | 0.8 | $7.5M | 2.5M | 3.00 | |
| Nautilus Biotechnology (NAUT) | 0.7 | $6.3M | 2.0M | 3.16 | |
| Xilio Therapeutics (XLO) | 0.7 | $5.9M | 2.8M | 2.11 | |
| 2seventy Bio Common Stock (TSVT) | 0.6 | $5.5M | 1.4M | 3.92 | |
| Adagio Therapeutics (IVVD) | 0.4 | $3.3M | 1.9M | 1.70 | |
| C4 Therapeutics Com Stk (CCCC) | 0.3 | $3.1M | 1.6M | 1.86 | |
| Newamsterdam Pharma Company *w Exp 11/22/202 (NAMSW) | 0.0 | $190k | 100k | 1.90 | |
| Cara Therapeutics (CARA) | 0.0 | $40k | 24k | 1.68 |
